In the preceding communication, Reiss, Hillman, Reiss, Daley and Haylock (1966) the influence of anabolic steroids on the blood phenylalanine level of chronic phenylketonuric patients was reported. It was hoped to reach a better understanding of the various changes observed by further investigations carried out on animals.This study involved : (1) changes in the blood phenylalanine concentration in rabbits after intraperitoneal injection of phenylalanine and the influence of anabolic hormones on these changes; (2) the influence of anabolic hormones on the blood, brain and liver phenylalanine and tyrosine content of phenylalanine-fed rats and (3) the phenylalanine hydroxylase activity of the liver of the phenylalanine-fed animals with and without treatment with anabolic steroids.
MATERIALWhite New Zealand rabbits weighing from 2.2 kg. to 2.7 kg. were used, litter-mates of the same sex being taken for each experiment. Sprague-Dawley rats from our own colony were 17 to 20 days of age when placed on experiment.The basic diet fed to the rats, both control and experimental animals, consisted of ground Purina Labchow with 18% Starlac powdered milk and 8.7% Mazola corn oil, as described by Yuwiler, et al. (1965).The diet fed to the experimental animals was supplemented with 6% 1-phenylalanine and 2% d-phenylalanine. Food and water were available ad libitum.
PREPARATIONSWY-4071 (Wyeth Laboratories) dl-13-ethyl-17/8-hydroxygon-4-en-3-one decanoate, a long acting slowly absorbed anabolic steroid. Bovine growth hormone. Lot B-9, supplied by the Endocrinology Study section of National Institute of Health.* * In a biological assay on rat uterus it was found that 1.0 mg. ol this preparation contained 0.02 i.u. of oxytocin. In order to exclude the possibility that this oxytocin contamination could be reponsible for the action of intravenously injected growth hormone, as described in Table I, control experiments were carried out using 1.0 i.u. of oxytocin. No reduction in the plasma phenylalanine content was observed.